The purpose of the registry is to evaluate the peri-operative and short-, mid- and long-term outcomes of the Bard Covera Plus (Tempe, Arizona, USA) for the treatment of atherosclerotic aorto-iliac aneurysm in combination with a multibranched endograft
Study Type
OBSERVATIONAL
Enrollment
300
atherosclerotic aorto-iliac aneurysm
technical success
freedom from type I or type III endoleak, stenosis/occlusion, dislocation/kinking
Time frame: 30 days
Branch instability
freedom from branch-related complications
Time frame: 30 days
Primary clinical success
freedom from death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University Heart & Vascular Center
Hamburg, Germany
Ludwig-Maximilians University Hospital
Munich, Germany
Ospedale di Asti
Asti, Italy
Ospedale Giuseppe Moscati
Avellino, Italy
Azienda Ospedaliero Universitaria Consorziale Policlinico
Bari, Italy
Fondazione Poliambulanza
Brescia, Italy
Azienda Ospedaliera di Cosenza
Cosenza, Italy
Azienda Ospedaliera Santa Croce e Carle
Cuneo, Italy
Ospedale civile San Giovanni di Dio
Florence, Italy
Ospedale Policlinico San Martino
Genova, Italy
...and 23 more locations